|
Reference | Age | Presentation | Tumor location | Dexamethasone dose | Initial radiographic change | Time to reoccurrence | Treatment | Outcome |
|
[2] | 56 M | Right facial palsy, dysphagia, and unsteady gait | Left frontoparietal lobe | 2 mg every 8 hours | Disappearance of tumor and contrast enhancement | 3 weeks; reappearance, same location | None | Death immediately after tissue biopsy, ~3 weeks after initial radiographic change |
[5] | 59 M | Headache and confusion | Left parietal lobe | 16 mg every 24 hours | Reduction in contrast enhancement | 4 weeks; reappearance, same location | Not reported | Not reported |
[4] | 61 F | Left hemiparesis, paresthesia | Right temporal lobe, right frontal lobe, splenium | 4 mg every 6 hours for 2 weeks | Near-complete resolution of all lesions | 4 weeks; increased size, new focus | Radiotherapy | Death ~5 months after initial radiographic change |
[7] | 53 M | Seizure | Right parietal lobe, corpus callosum | 4 mg every 6 hours for 3 weeks | Reduced enhancement in right parietal lobe, increased enhancement in corpus callosum | 3 weeks | Radiotherapy | Not reported |
[7] | 75 M | Confusion, short-term memory loss | Right parietal lobe, posterior corpus callosum | 4 mg every 6 hours for 3 weeks | Resolution of right parietal lesion, increased enhancement in splenium | 3 weeks | None | Death prior to commencing radiotherapy |
This paper | 57 F | Short-term memory loss, unsteady gait | Right temporoparietal lobe, splenium | 4 mg every 6 hours for 5 days | Reduction in contrast enhancement | 2 weeks; increased size, new focus, leptomeningeal spread | Chemotherapy with temozolomide, radiotherapy | Clinically stable 2 months after initial radiographic change |
|